UH
ELV icon

Unigestion Holding’s Elevance Health ELV Stock Holding History

Unigestion Holding’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-30,849
Closed -$11.4M – 168
2024
Q4 		$11.4M Sell
30,849
-11,101
-26% -$4.65M 0.66% 51
2024
Q3 		$21.8M Sell
41,950
-20,756
-33% -$11.1M 1.05% 42
2024
Q2 		$29.6M Buy
62,706
+3,018
+5% +$1.6M 1.63% 21
2024
Q1 		$31M Sell
59,688
-3,018
-5% -$1.5M 1.51% 24
2023
Q4 		$29.6M Sell
62,706
-14,019
-18% -$6.48M 1.63% 21
2023
Q3 		$33.4M Buy
76,725
+5,968
+8% +$2.71M 2.05% 18
2023
Q2 		$31.1M Buy
70,757
+33,953
+92% +$15.7M 1.8% 20
2023
Q1 		$16.9M Buy
36,804
+21,526
+141% +$10.2M 0.92% 40
2022
Q4 		$7.84M Buy
15,278
+7,324
+92% +$3.72M 0.42% 58
2022
Q3 		$3.63M Buy
7,954
+4,927
+163% +$2.36M 0.21% 79
2022
Q2 		$1.46M Buy
3,027
+627
+26% +$310K 0.08% 112
2022
Q1 		$1.21M Sell
2,400
-83
-3% -$37.9K 0.05% 122
2021
Q4 		$1.15M Sell
2,483
-690
-22% -$290K 0.05% 137
2021
Q3 		$1.23M Buy
3,173
+183
+6% +$69.5K 0.05% 117
2021
Q2 		$1.14M Hold
2,990
– – 0.04% 145
2021
Q1 		$1.07M Buy
2,990
+7
+0.2% +$2.25K 0.04% 150
2020
Q4 		$958K Buy
2,983
+1,413
+90% +$434K 0.03% 138
2020
Q3 		$422K Sell
1,570
-43,886
-97% -$11.8M 0.01% 164
2020
Q2 		$11.9M Sell
45,456
-117,985
-72% -$31.5M 0.4% 55
2020
Q1 		$37M Buy
+163,441
New +$44.5M 1.38% 22
2019
Q3 		$32M Buy
133,436
+35,331
+36% +$9.68M 0.89% 42
2019
Q2 		$27.7M Buy
98,105
+3,724
+4% +$1.02M 0.74% 54
2019
Q1 		$27.1M Sell
94,381
-1,935
-2% -$560K 0.72% 51
2018
Q4 		$25.3M Sell
96,316
-63,508
-40% -$17.5M 0.64% 55
2018
Q3 		$43.8M Sell
159,824
-29,093
-15% -$7.55M 0.93% 34
2018
Q2 		$45M Buy
+188,917
New +$43.7M 0.89% 37

Other funds holding ELV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

Unigestion Holding's ELV Position: Q1 2025 in Review

Unigestion Holding sold out of Elevance Health (ELV) in Q1 2025, closing a stake of 30,849 shares — an estimated $11.4M sold.

Unigestion Holding first reported a position in ELV in Q2 2018 and held it in 26 quarters. The position peaked at $45M in Q2 2018. 1,661 funds tracked by Wall St. Rank hold ELV as of Q1 2025.

  • Unigestion Holding reported no remaining Elevance Health position as of Q1 2025 after selling out during the quarter.
  • Unigestion Holding sold 30,849 Elevance Health shares in Q1 2025, an estimated $11.4M.
  • Unigestion Holding first reported a position in Elevance Health in Q2 2018 and held it in 26 quarters.
  • Unigestion Holding's Elevance Health position peaked at $45M in Q2 2018.
  • 1,661 funds tracked by Wall St. Rank held Elevance Health as of Q1 2025.

Based on Unigestion Holding's 13F filing for Q1 2025, filed 10 Apr 2025.